According to CareDx's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -14.5796. At the end of 2022 the company had a P/E ratio of -7.92.
Year | P/E ratio | Change |
---|---|---|
2022 | -7.92 | -89.72% |
2021 | -77.1 | -55.31% |
2020 | -172 | 315.86% |
2019 | -41.5 | 119.45% |
2018 | -18.9 | 469.13% |
2017 | -3.32 | 204.74% |
2016 | -1.09 | -80.42% |
2015 | -5.57 | -106.83% |
2014 | 81.5 |
Company | P/E ratio | P/E ratio differencediff. | Country |
---|---|---|---|
![]() | -0.0006 | -100.00% | ๐บ๐ธ USA |
![]() | -8.83 | -39.42% | ๐บ๐ธ USA |
![]() | -0.0060 | -99.96% | ๐บ๐ธ USA |
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.